Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate
The use of psychostimulants labeled to treat attention deficit/hyperactivity disorder increases. Among side effects these drugs raise blood pressure and heart rate, and the safety has been scrutinised in recent years. Data from large epidemiological studies, including over a million person-years, di...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2015/905097 |
id |
doaj-cdcf0ff1ac9f48e0b61ba623a1be13e8 |
---|---|
record_format |
Article |
spelling |
doaj-cdcf0ff1ac9f48e0b61ba623a1be13e82020-11-25T00:11:57ZengHindawi LimitedCase Reports in Pediatrics2090-68032090-68112015-01-01201510.1155/2015/905097905097Cardiac Arrest following a Myocardial Infarction in a Child Treated with MethylphenidateKim Munk0Lise Gormsen1Won Yong Kim2Niels Holmark Andersen3Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, DenmarkDepartment of Psychiatry, Aarhus University Hospital, Risskov Skovagervej 2, 8240 Risskov, DenmarkDepartment of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, DenmarkDepartment of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, DenmarkThe use of psychostimulants labeled to treat attention deficit/hyperactivity disorder increases. Among side effects these drugs raise blood pressure and heart rate, and the safety has been scrutinised in recent years. Data from large epidemiological studies, including over a million person-years, did not report any cases of myocardial infarction in current users of methylphenidate, and the risk of serious adverse cardiac events was not found to be increased. We present a case with an 11-year-old child, treated with methylphenidate, who suffered cardiac arrest and was diagnosed with a remote myocardial infarction. This demonstrates that myocardial infarction can happen due to methylphenidate exposure in a cardiac healthy child, without cardiovascular risk factors.http://dx.doi.org/10.1155/2015/905097 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kim Munk Lise Gormsen Won Yong Kim Niels Holmark Andersen |
spellingShingle |
Kim Munk Lise Gormsen Won Yong Kim Niels Holmark Andersen Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate Case Reports in Pediatrics |
author_facet |
Kim Munk Lise Gormsen Won Yong Kim Niels Holmark Andersen |
author_sort |
Kim Munk |
title |
Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate |
title_short |
Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate |
title_full |
Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate |
title_fullStr |
Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate |
title_full_unstemmed |
Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate |
title_sort |
cardiac arrest following a myocardial infarction in a child treated with methylphenidate |
publisher |
Hindawi Limited |
series |
Case Reports in Pediatrics |
issn |
2090-6803 2090-6811 |
publishDate |
2015-01-01 |
description |
The use of psychostimulants labeled to treat attention deficit/hyperactivity disorder increases. Among side effects these drugs raise blood pressure and heart rate, and the safety has been scrutinised in recent years. Data from large epidemiological studies, including over a million person-years, did not report any cases of myocardial infarction in current users of methylphenidate, and the risk of serious adverse cardiac events was not found to be increased. We present a case with an 11-year-old child, treated with methylphenidate, who suffered cardiac arrest and was diagnosed with a remote myocardial infarction. This demonstrates that myocardial infarction can happen due to methylphenidate exposure in a cardiac healthy child, without cardiovascular risk factors. |
url |
http://dx.doi.org/10.1155/2015/905097 |
work_keys_str_mv |
AT kimmunk cardiacarrestfollowingamyocardialinfarctioninachildtreatedwithmethylphenidate AT lisegormsen cardiacarrestfollowingamyocardialinfarctioninachildtreatedwithmethylphenidate AT wonyongkim cardiacarrestfollowingamyocardialinfarctioninachildtreatedwithmethylphenidate AT nielsholmarkandersen cardiacarrestfollowingamyocardialinfarctioninachildtreatedwithmethylphenidate |
_version_ |
1725402175881871360 |